Interstitial pneumonitis associated with pegylated interferon α-2b therapy for chronic hepatitis C: Case report

Annals of Hepatology

Volumn 7, Issue 1, 2008, Pages 87-90

  Carrillo Esper, Raúl ^a   González Avila, Daniela ^a   Uribe Ríos, Marittza ^a   Méndez Sánchez, Nahum ^a,b  

^a LIVER RESEARCH UNIT   (Mexico)

^b Biomedical Research

Author keywords

Chronic hepatitis C; Interstitial pneumonitis; Liver cirrhosis; Pegylated interferon

Indexed keywords

METHYLPREDNISOLONE; PEGINTERFERON ALPHA2B; PREDNISONE; RIBAVIRIN;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CAUSE OF DEATH; CHILL; CHOLESTATIC HEPATITIS; CORTICOSTEROID THERAPY; COUGHING; DRUG FATALITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEVER; HEMOPTYSIS; HEPATITIS C; HUMAN; INTERSTITIAL PNEUMONIA; LIVER CIRRHOSIS; LIVER INJURY; MALAISE; PLASMAPHERESIS; PLEURA EFFUSION; RESPIRATORY FAILURE; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 41549098708     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31895-2     Document Type: Article

References (18)

1. Strader DB, Wright T, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.
2. Chen YC, Lu S-N, Lin M-C. Interstitial pneumonitis after combination therapy with pegylated interferon α-2b and ribavirin for chronic hepatitis C. Chang Gung Med J 2007; 30: 92-7.
3. Tahan V, Ozseker F, Guneylioglu D, Baran A, Ozaras R, Mert A, Ucisik AC, et al. Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Dig Dis Sci 2003; 48: 169-73.
4. Kumar KS, Russo MW, Borczuk AC, Brown M, Esposito SP, Lobritto SJ, Jacobson IM, et al. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol 2002; 97: 2432-40.
5. Hizawa N, Kojima J, Kojima T, Sukoh N, Yamaguchi E, Kawakami Y, Matsushima T. A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration. Intern Med 1994; 33: 337-41.
6. Rönnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 115: 178-83.
7. Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: Case report and review of the literature. Clin Infect Dis 2004; 39: 1724-9.
8. Glue P, Fang JW, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, et al. Pegylated interferon-α2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group. Clin Pharmacol Ther 2000; 68: 556-67.
9. Kowdley KV. Hematological side effects of interferon and ribavirin therapy. J Clin Gastroenterol 2005; 39 Suppl 1: S3-S8.
10. Benítez C, Andresen M, Farías G, Castillo C, Henríquez M, Pereira J. Indications, adverse effects and results of plasmapheresis in critical care patients. Rev Med Chil 2005; 133: 1441-8.
11. + regulatory T cells in liver tissues of fibrosing cholestatic hepatitis after liver and kidney transplantation. Zhonghua Gan Zang Bing Za Zhi 2007; 15: 667-71.
12. Kojima H, Abei M, Takei N, Mukai Y, Hasegawa Y, Iijima T, Nagasawa T. Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis. Eur J Hematol 2002; 69: 101-4.
13. Izquierdo MT, Almenar L, Zorio E, Martinez-Dolz L. Viral hepatitis C-related fibrosing cholestatic hepatitis after cardiac transplantation. Med Clin (Barc) 2007; 129: 117-8.
14. Hooda AK, Puri P, Narula AS, Raychaudhury N, Varghese SJ, Basu A. Hepatitis C virus-related fibrosing cholestatic hepatitis in a renal transplant recipient. Indian J Gastroenterol 2006; 25: 308-9.
15. Chen JW, Chen DZ, Chen ZM. Unique pattern of fibrosing cholestatic hepatitis after liver transplantation. Hepatobiliary Pancreat Dis Int 2002; 1: 33-4.
16. Saleh F, Ko HH, Davis JE, Apiratpracha W, Powell JJ, Erb SR, Yoshida EM. Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis. Ann Hepatol 2007; 6: 186-9.
17. Abi-Nassif S, Mark EJ, Fogel RB, Hallisey RK Jr. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS. Chest 2003; 124: 406-10.
18. Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest 1994; 105: 939-41.